These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 23324517)

  • 1. The prevalence and ingredient cost of chronic comorbidity in the Irish elderly population with medication treated type 2 diabetes: a retrospective cross-sectional study using a national pharmacy claims database.
    O'Shea M; Teeling M; Bennett K
    BMC Health Serv Res; 2013 Jan; 13():23. PubMed ID: 23324517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and incidence of type 1 diabetes in Ireland: a retrospective cross-sectional study using a national pharmacy claims data from 2016.
    Gajewska KA; Biesma R; Sreenan S; Bennett K
    BMJ Open; 2020 Apr; 10(4):e032916. PubMed ID: 32312725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Total and component health care costs in a non-Medicare HMO population of patients with and without type 2 diabetes and with and without macrovascular disease.
    Gandra SR; Lawrence LW; Parasuraman BM; Darin RM; Sherman JJ; Wall JL
    J Manag Care Pharm; 2006 Sep; 12(7):546-54. PubMed ID: 16981800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost of diabetes: comparison of disease-attributable and matched cohort cost estimation methods.
    Tunceli O; Wade R; Gu T; Bouchard JR; Aagren M; Luo W
    Curr Med Res Opin; 2010 Aug; 26(8):1827-34. PubMed ID: 20491613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regional variation in medication-taking behaviour of new users of oral anti-hyperglycaemic therapy in Ireland.
    O'Shea MP; Teeling M; Bennett K
    Ir J Med Sci; 2015 Jun; 184(2):403-10. PubMed ID: 24859371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug usage patterns and treatment costs in newly-diagnosed type 2 diabetes mellitus cases, 2007 vs 2012: findings from a large US healthcare claims database analysis.
    Weng W; Liang Y; Kimball ES; Hobbs T; Kong S; Sakurada B; Bouchard J
    J Med Econ; 2016 Jul; 19(7):655-62. PubMed ID: 26855139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An observational study examining the effect of comorbidity on the rates of persistence and adherence to newly initiated oral anti-hyperglycaemic agents.
    O'Shea MP; Teeling M; Bennett K
    Pharmacoepidemiol Drug Saf; 2013 Dec; 22(12):1336-44. PubMed ID: 24142802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interrogation of a longitudinal, national pharmacy claims dataset to explore factors that predict the need for add-on therapy in older and socioeconomically disadvantaged Australians with type 2 diabetes mellitus patients (T2DM).
    Kumar SS; McManus H; Radovich T; Greenfield JR; Viardot A; Williams KM; Cronin P; Day RO
    Eur J Clin Pharmacol; 2018 Oct; 74(10):1327-1332. PubMed ID: 29938343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regional variation in prescribing for chronic conditions among an elderly population using a pharmacy claims database.
    Naughton C; Bennett K; Feely J
    Ir J Med Sci; 2006; 175(3):32-9. PubMed ID: 17073245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and co-prevalence of comorbidities among Chinese adult patients with type 2 diabetes mellitus: a cross-sectional, multicenter, retrospective, observational study based on 3B study database.
    Ji Q; Chai S; Zhang R; Li J; Zheng Y; Rajpathak S
    Front Endocrinol (Lausanne); 2024; 15():1362433. PubMed ID: 38919489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An evaluation of prescribing trends and patterns of claims within the Preferred Drugs Initiative in Ireland (2011
    McDowell R; Bennett K; Moriarty F; Clarke S; Barry M; Fahey T
    BMJ Open; 2018 Apr; 8(4):e019315. PubMed ID: 29678966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sex differences in treatment patterns of six chronic diseases: an analysis from the German statutory health insurance.
    Stock SA; Stollenwerk B; Redaelli M; Civello D; Lauterbach KW
    J Womens Health (Larchmt); 2008 Apr; 17(3):343-54. PubMed ID: 18338965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The implications of regional and national demographic projections for future GMS costs in Ireland through to 2026.
    Conway A; Kenneally M; Woods N; Thummel A; Ryan M
    BMC Health Serv Res; 2014 Oct; 14():477. PubMed ID: 25335968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measuring medication adherence in older community-dwelling patients with multimorbidity.
    Kim S; Bennett K; Wallace E; Fahey T; Cahir C
    Eur J Clin Pharmacol; 2018 Mar; 74(3):357-364. PubMed ID: 29199370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticholinergic and sedative drug burden in community-dwelling older people: a national database study.
    Byrne CJ; Walsh C; Cahir C; Ryan C; Williams DJ; Bennett K
    BMJ Open; 2018 Jul; 8(7):e022500. PubMed ID: 29982221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics Relating to Adherence and Persistence to Basal Insulin Regimens Among Elderly Insulin-Naïve Patients with Type 2 Diabetes: Pre-Filled Pens versus Vials/Syringes.
    Slabaugh SL; Bouchard JR; Li Y; Baltz JC; Meah YA; Moretz DC
    Adv Ther; 2015 Dec; 32(12):1206-21. PubMed ID: 26563324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multimorbidity in people with type 2 diabetes in the Basque Country (Spain): Prevalence, comorbidity clusters and comparison with other chronic patients.
    Alonso-Morán E; Orueta JF; Esteban JI; Axpe JM; González ML; Polanco NT; Loiola PE; Gaztambide S; Nuño-Solinís R
    Eur J Intern Med; 2015 Apr; 26(3):197-202. PubMed ID: 25701236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adherence and persistence to urate-lowering therapies in the Irish setting.
    McGowan B; Bennett K; Silke C; Whelan B
    Clin Rheumatol; 2016 Mar; 35(3):715-21. PubMed ID: 25409858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Economic outcomes of exenatide vs liraglutide in type 2 diabetes patients in the United States: results from a retrospective claims database analysis.
    Pelletier EM; Pawaskar M; Smith PJ; Best JH; Chapman RH
    J Med Econ; 2012; 15(6):1039-50. PubMed ID: 22533526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determining the cost of obesity and its common comorbidities from a commercial claims database.
    Padula WV; Allen RR; Nair KV
    Clin Obes; 2014 Feb; 4(1):53-8. PubMed ID: 25425133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.